Comparison 22. Sensitivity analysis 2: excluding studies with unclear or high risk of bias on random sequence generation.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
22.1 Rate of falls ‐ exercise vs control	7	995	Rate Ratio (IV, Random, 95% CI)	0.90 [0.76, 1.05]
22.2 Number of fallers ‐ exercise vs control	5	516	Risk Ratio (IV, Random, 95% CI)	0.89 [0.76, 1.04]
22.3 Rate of falls ‐ cholinesterase inhibitor vs placebo	1	129	Rate Ratio (IV, Fixed, 95% CI)	0.60 [0.38, 0.96]
22.3.1 Rivastigmine vs placebo	1	129	Rate Ratio (IV, Fixed, 95% CI)	0.60 [0.38, 0.96]
22.4 Number of fallers ‐ cholinesterase inhibitor vs placebo	1	130	Risk Ratio (IV, Fixed, 95% CI)	1.00 [0.87, 1.15]
22.4.1 Rivastigmine vs placebo	1	130	Risk Ratio (IV, Fixed, 95% CI)	1.00 [0.87, 1.15]